Navigation Links
Inovio Pharmaceuticals' Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
Date:10/5/2011

BLUE BELL, Pa., Oct. 5, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that the company's research to develop a therapeutic synthetic vaccine for cancer won the Edward Jenner Poster Award First Prize at the recent 5th Vaccine and ISV Global Congress. This prestigious prize recognizes the most promising research at the Congress. Inovio's poster, entitled "Induction of HPV specific CTLs in human volunteers after DNA immunization," was selected from over 500 abstracts by the scientific organizing committee and an expert panel of judges. The award citation highlighted Inovio's pioneering therapeutic cervical dysplasia/cancer vaccine program and the novel assay for determining vaccine impact.

The Vaccine Congress is a forum for a state-of-the-art report on the latest progress in the development of vaccines for infectious and non-infectious diseases. The annual Jenner Award is named after Edward Jenner (1749-1823), who is widely credited as the pioneer of the smallpox vaccine and is often referred to as the "Father of Immunology."

Inovio presented data showing the development of a novel flow cytometry-based assay to assess cytolytic T cell (CTL) activity in immunized patients. Blood samples collected from subjects immunized with Inovio's SynCon® therapeutic HPV 16 and 18 vaccine (VGX-3100) were analyzed by the new assay. Inovio previously announced the results of its Phase I clinical trial demonstrating the induction of strong T-cell immune responses to the vaccine. An important aspect of a therapeutic vaccine is its ability to generate antigen-specific cytolytic CD8+ T cells that can kill infected host cells. Using the new assay, Inovio scientists were able to demonstrate for the first time that the vaccines developed fully functional CTLs ca
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Strategic Health Services, Inc. (SHS), a leading provider of ... agreement with QualCare, Inc., a leading provider of health plans ... marketplace.  This agreement will further QualCare,s population health management ... brings to its clients in New Jersey ... QualCare plans cover more than 800,000 member lives, with ...
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, Inc. ... music products, today announced that it has signed ... manufacturer and supplier of innovative prosthetic, orthotic and ... part of the agreement, RSL Steeper will promote ... specifically configured for use within UK residential care ...
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI ... China, today announced financial results for the quarter ended March 31, ... , Revenue was $16.1 million, compared to $18.1 million ... million, compared to $6.9 million in the prior year period; ...
... Cloud-based Veeva CRM Now Deployed in Over 20 European ... Customer Summit kicking off this morning in Philadelphia, Veeva Systems ... Since Veeva,s official expansion into Europe in April 2010, the ... than 35 life sciences companies across 20+ different European markets. ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 2China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 3China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 4China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 5China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 6China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 7China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results 8Veeva Systems Announces Dramatic Growth in Europe 2Veeva Systems Announces Dramatic Growth in Europe 3Veeva Systems Announces Dramatic Growth in Europe 4
(Date:12/21/2014)... Dennis Thompson HealthDay Reporter ... tobacco smokers find e-cigarettes less addictive than traditional cigarettes, new ... often as they did regular cigarettes, thousands of ex-smokers said ... impulsive and irritable over their need to smoke, researchers reported. ... score was significantly less for e-cig use than for tobacco ...
(Date:12/21/2014)... NY (PRWEB) December 21, 2014 The ... 1,400 in a consolidated litigation underway in New Jersey, ... a total of 1,375 claims involving the birth control ... Court. These lawsuits were filed by women who allege ... have led to uterine perforations and other complications they ...
(Date:12/21/2014)... San Francisco, California (PRWEB) December 21, 2014 ... announces his search for Vintage 1967 Jm Morrison and the ... D.C. concert posters. This would also be the only ... live. The concert was on Nov. 25, 1967. According ... in Washington D.C. They did play the Alexandria Roller ...
(Date:12/21/2014)... December 21, 2014 Over the past ... issues in hundreds of emergency departments across the nation, ... findings have been translated into an innovative suite of ... correct deficiencies and enhance the patient experience. , ... physician staffing and management services for hospitals, announced the ...
(Date:12/21/2014)... Viejo, California (PRWEB) December 21, 2014 ... Studios have announced a new intro plugin for Final ... to animate pictures, videos, logos, and more with absolute ... “We’ve given our users the tools needed to easily ... ProMotion allows Final Cut Pro X users to animate ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2
... News) -- Sleep deprivation may lead to overly optimistic ... of financial risks, a new study suggests. Duke ... 29 adult volunteers who were asked to take part ... a normal night of sleep and again one morning ...
... Patients with epilepsy worry more than their physicians do about ... to a recent study. In a survey, patients with ... important concern on a list of 20 potential medical or ... in the frequency of responses among concerns recorded by physicians ...
... , TUESDAY, March 8 (HealthDay News) -- ... hearing Tuesday to weigh the risks and benefits of ... their manufacturers contend, can help predict a person,s risk ... given medication. A panel of FDA advisers will ...
... not only the name of a 1970,s television police drama ... believe could be an important element in the fight against ... walls. Alpana Ray, research associate professor in the ... including Bimal Ray, professor of Veterinary Pathobiology, have been studying ...
... HealthDay Reporter , TUESDAY, March 8 (HealthDay News) -- The ... risk of metabolic syndrome, a cluster of risk factors that ... to a new review. Researchers from Greece and Italy ... of more than 500,000 participants as part of a meta-analysis ...
... Your brain,s ability to learn may get recharged during the ... your night,s sleep, according to a new study. Researchers ... healthy young adults and found strong evidence that bursts of ... of the brain to clear a path to learning. ...
Cached Medicine News:Health News:Sleep Deprivation May Encourage Risky Decisions 2Health News:Epilepsy-linked memory losss worries more patients than doctors 2Health News:Epilepsy-linked memory losss worries more patients than doctors 3Health News:Epilepsy-linked memory losss worries more patients than doctors 4Health News:FDA Weighs Pros, Cons of Home Genetic Testing 2Health News:FDA Weighs Pros, Cons of Home Genetic Testing 3Health News:ADAM-12 gene could hold key to cancer, arthritis and cardiac treatments 2Health News:Mediterranean Diet Reduces Risk of Metabolic Syndrome 2Health News:Mediterranean Diet Reduces Risk of Metabolic Syndrome 3Health News:Brain's Learning Ability Seems to Recharge During Light Slumber 2
... is an economically priced 4-channel data ... research use in the fields of ... biology, zoology, biochemistry and biomedical engineering. ... signal conditioners and transducers. Two Pod ...
Printed with large 20/200 E on one side and a series of five 20/20 tumbling Es on the other- calibrated to a 20 ft. distance. May be used to test and train peripheral awareness....
... These Low Contrast Flip charts contain 5 ... Numbers on each page. Optotype size is 9.5M. ... 1.25%. These flip charts can be used at ... for the same test. Each offers a ...
... is a high-performance recording unit suitable for ... applications that require up to 16 input ... tissue studies. The unit is capable of ... 000 samples per second continuously to disk, ...
Medicine Products: